MGRC’s cancer treatment options are not limited to just CAR T-Cell Immunotherapy. We also offer alternative immunotherapies that may be more suited for the patient’s cancer prognosis.
Available Other
Immunotherapy Products
IMMUNOTHERAPY GENE PRODUCT | TYPE OF CANCER |
Tumour-Associated Antigen T-Cell (TAA-T) Therapy |
|
T-Cell Receptor T-Cell (TCR-T) Therapy |
|
Tumour-Infiltrating Lymphocyte (TIL) Therapy, Short Chain Variable Fragment Immune Checkpoint Inhibitors (scFv ICI)-PD-1, CD47 |
|
THE DIFFERENCE
Chemotherapy
VS Immunotherapy
While chemotherapy and immunotherapy both aim to rid the human body of cancerous cells, the way two treatments work differ vastly. We’ve laid out the differences to encourage informed decisions for everyone.